Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 29, 2017 - Issue 4
716
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Cosmetic talc as a risk factor for pleural mesothelioma: a weight of evidence evaluation of the epidemiology

, &
Pages 179-185 | Received 04 May 2017, Accepted 25 May 2017, Published online: 27 Jun 2017

References

  • ACGIH. (2001). Talc containing no asbestos fibers. CAS Nuumber: 14807-96-6. American Conference of Governmental Industrial Hygienists.
  • Addison J, Langer AM. (2000). Draft comments on the NTP draft report on carcinogens background document for talc asbestiform and non-asbestiform.
  • Agarwal R, Paul AS, Aggarwal AN, et al. (2011). A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis. Respirology 16:1064–9.
  • Ahmed Z, Shrager JB2. (2003). Mediastinal talcoma masquerading as thymoma. Ann Thorac Surg 75:568–9.
  • Banaei A, Auvert B, Goldberg M, et al. (2000). Future trends in mortality of French men from mesothelioma. Occup Environ Med 57:488–94.
  • Breslow NE, Day NE. (1987). Statistical methods in cancer research. Volume II – The design and analysis of cohort studies. IARC Sci Publ 82:1–406.
  • Brown R. (1985). Asbestos in Talc. In: Department of Health & Human Services. p. 11.
  • BTA. (1979). A survey of the long-term effects of talc and kaolin pleurodesis. Research Committee of the British Thoracic Association and the Medical Research Council Pneumoconiosis Unit. Br J Dis Chest 73:285–8.
  • Burguete SR, DeArmond DT, Soni NJ, Peters J. (2015). Part 9: disorders of the plueral space. In: Fishman’s pulmonary diseases and disorders. 5th ed. New York: McGraw Hill, 11–97.
  • Castro MJ, Jessurun J, Pambuccian SE, MS. (2012). Talc crystals in pleurodesis-associated talc granuloma. Diagn Cytopathol 40:617–18.
  • Caneer WT. (1973). Internal memo from W.T. Caneer (Colorado School of Mines Research Institute) to W.H. Ashton (Colorado School of Mines Research Institute), RE: Meeting with Bowling Green State University Geological Staff. Dated June 8, 1973.
  • Coggiola M, Bosio D, Pira E, et al. (2003). An update of a mortality study of talc miners and millers in Italy. Am J Ind Med 44:63–9.
  • Cralley LJ, Key MM, Groth DH, et al. (1968). Fibrous and mineral content of cosmetic talcum products. Am Ind Hyg Assoc J 29:350–4.
  • Dellisanti F, Minguzzi V, Morandi N. (2001–2002). Experimental results from thermal treatmetn of asbestos containing materials. GeoActa 1:61–70.
  • Faynberg T, Patel N, Nayar AP, Shienbaum AJ. (2017). Mesothelioid reaction following talc pleurodesis: a case report. Gen Thorac Cardiovasc Surg. [Epub ahead of print]. doi:10.1007/s11748-017-0758-0.
  • Ferrer J, Villarino MA, Tura JM, et al. (2001). Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 119:1901–5.
  • Fiume MM, Boyer I, Bergfeld WF, et al. (2015). Safety assessment of talc as used in cosmetics. Int J Toxicol 34:66S–129.
  • Honda Y, Beall C, Delzell E, et al. (2002). Mortality among workers at a talc mining and milling facility. Ann Occup Hyg 46:575–85.
  • IARC. (1987). IARC monographs on the evaluation of the carcinogenic risks to humans. Supplement 7 ed. Lyon, France: International Agency for Research on Cancer, World Health Oragnization.
  • IARC. (2010). IARC Monographs on the Evlauation of Carcinogenic Risks to Humans. Lyon, France: International Agency for Research on Cancer, World Health Organization.
  • Jackson JW, Bennett MH1. (1973). Chest wall tumour following iodized talc pleurodesis. Thorax 28:788–93.
  • Kennedy L, Sahn SA. (1994). Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 106:1215–22.
  • Kleinfeld M, Messite J, Kooyman O, et al. (1967). Mortality among talc miners and millers in New York State. Arch Environ Health 14:663–7.
  • Kleinfeld M, Messite J, Langer AM1. (1973). A study of workers exposed to asbestiform minerals in commercial talc manufacture. Environ Res 6:132–43.
  • Krause JB. (1977). Mineralogical characterization of cosmetic talc products. J Toxicol Environ Health 2:1223–6.
  • Lange P, Mortensen J, Groth S1. (1988). Lung function 22–35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage or simple drainage. Thorax 43:559–61.
  • Lanphear BP, Buncher CR1. (1992). Latent period for malignant mesothelioma of occupational origin. J Occup Med 34:718–21.
  • Marinaccio A, Binazzi A, Marzio DD, et al. (2012). Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer 130:2146–54.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269, W264.
  • Mowé G, Gylseth B, Hartveit F, Skaug V. (1984). Occupational asbestos exposure, lung-fiber concentration and latency time in malignant mesothelioma. Scand J Work Environ Health 10:293–8.
  • Neuberger M, Vutuc C. (2003). Three decades of pleural cancer and mesothelioma registration in Austria where asbestos cement was invented. Int Arch Occup Environ Health 76:161–6.
  • Rohl AN, Langer AM. (1974). Identification and quantitation of asbestos in talc. Environ Health Perspect 9:95–109.
  • Rohl AN, Langer AM, Selikoff IJ, et al. (1976). Consumer talcums and powders: mineral and chemical characterization. J Toxicol Environ Health 2:255–84.
  • Rohl AN, Langer AM. (1979). Fibrous mineral content of consumer talc-containing products. In: Lemen R, Dement JM, (eds.) Dusts and disease. Park Forest South, IL: Pathotox Publishers, 393–403.
  • Rubino GF, Scansetti G, Piolatto G, Gay G. (1979) Mortality and morbidity of talc miners and millers in Italy. In: Lemen R, Dement JM, (eds.) Proceedings of the dusts and disease; 1977. The Society for Occupational and Environmental Health.
  • Rubino GF, Scansetti G, Piolatto G, Romano CA1. (1976). Mortality study of talc miners and millers. J Occup Med 18:187–93.
  • Sahn SA. (2000). Talc should be used for pleurodesis. Am J Respir Crit Care Med 162:2023–6.
  • Selevan SG, Dement JM, Wagoner JK, Froines JR. (1979). Mortality patterns among miners and millers of non-asbestiform talc: preliminary report. J Environ Pathol Toxicol 2:273–84.
  • Snider DW, Pfeiffer DE, Mancuso JJ. (1972). Asbestosform impurities in commercial talcum powders. Compass of Sigma Gamma Epsilon. 49:65–67.
  • Stille WT, Tabershaw IR1. (1982). The mortality experience of upstate New York talc workers. J Occup Med 24:480–4.
  • Stroup DF. (2000). Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 283:2008.
  • Swanson JW. (1986). Memo from JW Swanson (Acting Associate Commissioner for Regulatory Affirs - US Food and Drug Adminstration) to Mr. Phillippe Douillet, RE: Docket Number 1982P-404, Denying a November 8, 1983, Petition Requesting that Cosmetic Talc be Labeled with an Asbestos Warning Statement (Includes Enclosures/Talc Documents). Dated July 11, 1986.
  • Ulvestad B, Kjaerheim K, Møller B, Andersen A. (2003). Incidence trends of mesothelioma in Norway, 1965–1999. Int J Cancer 107:94–8.
  • USEPA. (1992). Health assessment document for talc. Research Triangle Park, NC: Office of Health and Environmental Assessment.
  • USP. (1981). Talc. In: FCC111, Monographs. Rockville, MD: United States Pharmacopeial Convention, 318–19.
  • USP. (2011). Revision Bulletin: Talc. August 1, 2011. Accessed April 6, 2016. Available from: http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/revisions/m80360talc.pdf In.
  • USPC. (2016). Reference Standards: U.S. Pharmacopeial Convention; [cited 05/01/17 2017]. Available from: http://www.usp.org/reference-standards.
  • Vandemoortele T, Laroumagne S, Roca E, et al. (2014). Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of Benign Talcoma. Respiration 87:243–8.
  • Virta RL. (2002). Asbestos: geology, mineralogy, mining, and uses. Reston, VA: U.S. Department of the Interior. U.S. Geological Survey. Open-File Report 02-149.
  • Viskum K, Lange P, Mortensen J. (1989). Long term sequelae after talc pleurodesis for spontaneous pneumothorax. Pneumologie. 43:105–106.
  • Wagner JC, Berry G, Cooke TJ, et al. (1975). Animal experiments with talc. In: Walton WH, McGovern B, (eds.) Proceedings of the International Symposium organized by the British Occupational Hygiene Society; 1977. New York: Pergamon Press.
  • Wagner JC, Berry G, Hill RJ, et al. (1979). An animal model for inhalation exposure in talc. In: Dusts and disease. Illinois: Pathotox Publishers, 389–92.
  • Wegman DH, Peters JM, Boundy MG, et al. (1982). Evaluation of respiratory effects in miners and millers exposed to talc free of asbestos and silica. Br J Ind Med 39:233–8.
  • Wergeland E, Andersen A, Baerheim A1. (1990). Morbidity and mortality in talc-exposed workers. Am J Ind Med 17:505–13.
  • Wild P, Leodolter K, Refregier M, et al. (2002). A cohort mortality and nested case-control study of French and Austrian talc workers. Occup Environ Med 59:98–105.
  • Williams T, Gostelow B, Woods D, et al. (1998). Apical pleural mass developing following talc pleurodesis. Respir Med 92:358–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.